Recruiting OBSERVATIONAL NCT03893136

The Registry Study of Takayasu Arteritis in East China

The Cohort Study of East Chinese Takayasu's Arteritis (ECTA-cohort Study)

Sponsor: Shanghai Zhongshan Hospital

Conditions Mechanisms, Defense Outcome Pregnancy Related Takayasu Arteritis Treatment Refusal

Updated 8 times since 2019 Last updated: Aug 7, 2021 Started: Nov 1, 2016 Primary completion: May 31, 2026 Completion: May 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Mechanisms, Defense and Outcome and is currently actively recruiting participants. Shanghai Zhongshan Hospital leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Dec 2021 — Jul 2024 [monthly]

Recruiting
Sep 2021 — Dec 2021 [monthly]

Recruiting
Jan 2021 — Sep 2021 [monthly]

Recruiting

▶ Show 3 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting
Jun 2020 — Nov 2020 [monthly]

Recruiting
Apr 2019 — Jun 2020 [monthly]

Recruiting

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Zhongshan Hospital

Data source: Shanghai Zhongshan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China